The latest health and pharmaceuticals industry and company news and analysis from FriedlNews
Page 1/9

Austrian Health and Pharma Headlines

Latvia's Silvanols Drug Company Begins Exports to Austria

Latvian pharmaceutical company Silvanols has started exports to Austria, the company announced. Silvanols has begun exporting Venocaps, a product for leg veins, in cooperation with Takeda Pharma Ges.m.g.H., the Austrian representation office of Japan’s Takeda Pharmaceutical Company Limited.

May 21, 2015

Valneva Profited from Crucell Acquisition in Q1

The listed biotech firm Valneva improved revenue and income in Q1 2015 thanks to the acquisition of Swedish Crucell. Sales hiked from EUR 7.1 to 19.5 million, whereas the company’s net loss of EUR 7.1 million (USD 7.9 million) was reduced to EUR 5 million. The comparative figures have not been adjusted though.

May 12, 2015

Baxter's Division, Baxalta, to Invest EUR 138 Million in Krems

International pharmaceutical and biotechnology giant Baxter under the name Baxalta will in the coming three years invest EUR 138 million (USD 156.7 million) in the expansion and modernization of production facility Krems. From 2018 the factory will be producing a medicine for blood clotting.

May 8, 2015

Antibiotics Company Nabriva Therapeutics Collects USD 120 Mln from Investors

Viennese biotech firm Nabriva Therapeutics, specialized in antibiotics against resistant bacteria, has collected USD 120 million from investors. The financing process took two tranches, law firm Wolf Theiss, which advised investors together with US firm Cooley, announced on Wednesday.

April 9, 2015

Vamed to Manage First Hospital in China

Vamed is about to establish and manage its first hospital in China - in the provincial capital Haikou on the island of Hainan.

March 30, 2015

Valneva Biotech Target Price Cut to EUR 4.9, 'Hold' Maintained

Listed vaccine producer Valneva, formerly Intercell, had its target price reduced slightly to EUR 4.9 (USD 5.3) from EUR 5.1 with the recommendation kept at 'hold' at Erste Group.

March 9, 2015

Online Pharmacies: Dispatch of OTC Medication in Austria Allowed

As of 25 June 2015 Austrian pharmacies are allowed to sell over-the-counter pharmaceuticals online. The basis for Austrian regulations is the Falsified Medicines Directive, already transposed into Austrian law. In a regulation yet to get an opinion, duties of pharmacies will be determined.

March 3, 2015

Valneva Biotech Reduces 2014 EBITDA Loss to EUR 7.4 Mln

Listed vaccine produce Valneva, formerly Intercell, posted a preliminary EUR 7.4 million (USD 8.4 million) EBITDA loss in 2014, better than EUR 11.7 million loss a year earlier, the company said Thursday.

February 26, 2015

Health Insurance Industry Expects EUR 129 Million Deficit

Austria’s health insurance fund managers expect after several years of surplus to generate a deficit again this year. According to the latest estimates of the Chief Association of Social Insurance Agencies (Hauptverband der Sozialversicherungsträger) the deficit might reach EUR 128.9 million (USD 147 million) in 2015, which marks a hefty drop from last year’s surplus of EUR 83 million (USD 94.9 million).

February 16, 2015

Valneva Completes EUR 45 Million Capital Increase

The listed biotechnology company Valneva SE announces the completion of its capital increase with shareholders preferential subscription rights launched on January 12th, 2015. Valneva estimates net proceeds of EUR 42 millions from 18.2 million offered new shares. The new ordinary shares will be traded on Euronext and on the Prime Market segment of the Vienna Stock Exchange. The financing will mainly be used for the acquisition of Crucell Sweden AB and all assets, licenses and privileges related to Dukoral.

February 4, 2015